Treating ALK-positive non-small cell lung cancer

Targeting genomic alterations, such as epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) gene rearrangements, have radically changed the treatment of patients with non-small cell lung cancer (NSCLC). In the case of ALK-rearranged gene, subsequent rapid developmen...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Transl Med
Главные авторы: Ziogas, Dimitrios C., Tsiara, Anna, Tsironis, Georgios, Lykka, Maria, Liontos, Michalis, Bamias, Aristotelis, Dimopoulos, Meletios-Athanasios
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2018
Предметы:
Review Article on Breakthroughs in the Treatment of Advanced Lung Cancer: Making Progress Through Innovation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5952030/
https://ncbi.nlm.nih.gov/pubmed/29862230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.11.34
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы